Anaeropharma Science Inc. headquartered in Tokyo (hereafter "Anaeropharma") has announced that Anaeropharma and Ast...
Accenture and Merck, known as MSD outside the United States and Canada, in collaboration with Amazon Web Services (AWS),...
Singapore - Pfizer announced its investigational oral Janus kinase 3 (JAK3) inhibitor PF-06651600 received Breakthr...
China-based Chi-Med has announced that fruquintinib capsules have been granted approval for drug registration by the Nat...
China's commercial-stage biopharmaceutical company BeiGene, recently announced the acceptance by the Ch...
Singapore- The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of ne...
India's Strides Pharma has announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limite...
Edmonton's General Intermediates of Canada Inc. (GIC) has received conditional funding from the National Research Counci...
Roche recently announced that the China National Drug Administration (CNDA) has granted marketing authorization fo...
HitGen Ltd has announced a multi-year major drug discovery research collaboration with LG Chem to identify novel small m...
Blueberry Therapeutics Limited, a drug discovery and development company focused on developing innovative nanomedicines ...
The Buck Institute, Juvenescence, and Insilico Medicine have announced a research collaboration utilizing artificial int...
Singapore – The U.S. Food and Drug Administration recently approved Galafold (migalastat), the first oral medicati...
Pfizer China announced that the China National Drug Administration (CNDA) has granted approval of IBRANCE® (palbocic...
Singapore – DotBio, a new company focused on the development of novel immuno-oncology drugs based on humanize...
MedPacto, that announced today a clinical collaboration with AstraZeneca to evaluate the safety and efficacy of MedPacto...
Singapore – The European Commission approves Pfizer's TRAZIMERA, a biosimilar of Roche's cance...
Singapore- The FDA accepts for review Nektar Therapeutics' marketing application seeking approval for NK...
Singapore – The FDA approves Agios Pharmaceuticals' TIBSOVO (ivosidenib) for the treatment of adult pati...
Singapore – US Food and Drug Administration approves Pfizer’s Neupogen biosimilar Nivestym and is expected t...
Singapore – The U.S. Food and Drug Administration approved TPOXX (tecovirimat), the first drug wit...
Immatics Biotechnologies GmbH, a clinical-stage biopharmaceutical company active in the discovery and development of T-c...
Singapore – Eagle Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted seve...
OBI Pharma, a Taiwan biopharma company, has announced that the U.S. Food and Drug Administration (FDA) has gra...
Singapore – Eisai and Biogen have announced positive topline results from the Phase II study with BAN2401, an...
Global pharma giant recently announced that its drug candidate for cancer- the combination of Tecentriq (atezolizumab) p...
Singapore – Scientists and clinicians from Singapore institutes are collaborating with C&C Research ...
LUMICKS, a world leader in dynamic single-molecule analysis, has partnered with AstraZeneca and the University of Cambri...
Ascletis BioScience Co., Ltd. and CR Pharmaceutical Commercial Group Co., Ltd. have jointly announced that the two parti...
Singapore - AUM Biosciences (AUM), a new company focused on the development of innovative and affordable oncology m...
Global pharmaceutical company Mylan has announced the US launch of Bivalirudin for Injection, 250 mg singl...
Ascletis (partner of WuXi STA) receives approval from National Drug Administration of China (CNDA, former CFDA) of its C...
Insilico Medicine, a Baltimore-based next-generation artificial intelligence company specialized in the application of d...
Singapore- TESARO, an oncology-focused biopharmaceutical company, announced that it has entered into a clinical co...
Japan’s Astellas Pharma recently announced that the U.S. Food and Drug Administration (FDA) has accepted, with Pri...
Singapore- Versartis and Aravive Biologics jointly announced that they have entered into a definitive agreement under wh...
Singapore- Blueprint Medicines and CStone Pharmaceuticals, a privately-held biopharmaceutical company announce an e...
Singapore- Eli Lilly and Company and Incyte Corporation announced that the U.S. Food and Drug Administration (FDA) has a...
Singapore- Amgen, in a two-sentence announcement, said it received a complete response letter for the biosimilar of Roch...
Global drug giant, Roche recently announced that the European Commission has approved Perjeta (pertuzumab) in combinatio...
LUYE PHARMA announced that the Group entered into a collaboration and license agreement with Elpis Biopharm, a Boston-re...
Singapore- U.S. regulators approved BioMarin Pharmaceutical Inc’s Palynziq for adults with phenylketonuria, a rare...
Eisai Inc. and Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced that the U.S. Food and Dr...
Singapore- Celgene and German biotech Evotec AG have inked a long-term strategic drug discovery and development par...
Global drug giant, AstraZeneca has submitted a supplemental new drug application (sNDA) to Japan’s Pharmaceuticals...
Singapore- Minerva Neurosciences, a clinical-stage biopharmaceutical company focused on the development of therapi...
Singapore- The European Commission (EC) has approved commercialization partner Ipsen's marketing application for C...
Singapore- Regeneron Pharmaceuticals and development partner Sanofi announce positive preliminary data from a...
Singapore- Dicerna Pharmaceutical’s drug recently received an orphan drug status designation for i...
Singapore- The U.S. Food and Drug Administration approved privately held US WorldMeds LLC's Lucemyra (lofexidine hydroch...
Singapore– Daré Bioscience, a clinical-stage women’s biopharmaceutical company has agreed t...
Kindred Biosciences, Inc. a biopharmaceutical company focused on saving and improving the lives of pets, announced that ...
Singapore – Shanghai-based Zai Lab Limited inks an exclusive license agreement with privately held Entasis Therape...
Pfizer recently announced that its lead Meningococcal Group B Vaccine TRUMENBA received Breakthrough Therapy designation...
Singapore - Zymeworks, a clinical-stage biopharmaceutical company developing multifunctional therapeutics, announced tha...
Singapore- Belgium based UCB announced an agreement to acquire the rights to Proximagen's Midazolam Nasal Spray (US...
Singapore- Johnson & Johnson will implement a new pricing and dosage scheme for cancer med IMBRUVICA (ibrutinib) con...
OBI Pharma, Inc., a Taiwan biopharma company announced that the U.S. Food and Drug Administration (FDA) has cleared an i...
Perrigo and its Israel based partner, Dexcel Pharma announced the launch of store brand omeprazole delayed release orall...
Pfizer recently announced that it has initiated a Phase 1b clinical trial for its mini-dystrophin gene therapy candidate...
Strides Shasun said its wholly-owned subsidiary has received approval from the US health regulator for Cyproheptadine Hy...
M&A deal making continues with Alexion Pharmaceuticals swapping up Wilson Therapeutics AB for USD 855 millio...
Singapore - Perrigo Company plc announced that it has received final approval from the U.S. Food & Drug Administrati...
US-based Ionis Pharmaceuticals, the leader in antisense therapeutics, recently announced that it has licensed IONI...
As per reports from a leading South Korean daily, the country’s leading pharmaceutical firm Yuhan Corporation has ...
Global pharma giant AstraZeneca’s oncology drugs received regulatory boost with bothe the US FDA and EU accepting ...
Singapore - Aleafia Health announced that it has launched a new opiate replacement program across its 23 Aleafia/Canabo ...
Singapore — Proteostasis Therapeutics, a clinical stage biopharmaceutical company dedicated to the discovery and d...
Drug firm Strides Shasun has received approval from the US health regulator for generic Ibuprofen capsules, 200 mg, used...
UK based drug discovery company C4X Discovery Holdings plc has announced that it has signed a licensing agreement with I...
Singapore – Breckenridge Pharmaceutical announced that the U.S. Food and Drug Administration has gran...
Singapore - Esco Aster, a leading independent contract development and manufacturing organization underpinned by its pat...
Merck, a leading science and technology company, will introduce three new products for the flexible manufacturing of bio...
Singapore - Ablynx’ vobarilizumab has failed to hit targets in a mid-stage trial assessing its safety and effectiv...
Carna Biosciences, Inc. and Sumitomo Dainippon Pharma Co., Ltd. have signed an agreement on joint research with the aim ...
Biocon's contract research arm Syngene International inked a drug discovery agreement with global drug firm GSK. The mu...
Singapore - Researchers from the Los Angeles Biomedical Research Institute and the University of Washington...
Suven Life Sciences has announced that it has been granted a patent each by Norway, South Korea ...
Allergan plc announces the launch of Ozurdex® (dexamethasone intravitreal implant 0.7 mg) in China for the treatment...
Inovio Pharmaceuticals, today announced that it has inked an agreement providing ApolloBio with the exclusive right to d...
Pfizer and Astellas Pharma announced that a supplemental New Drug Application (sNDA) for XTANDI (enzalutamide) has been ...
Biogen recently announced that it has inked an agreement to acquire investigational candidate for schizophrenia from Pfi...
Korea’s JW Pharmaceutical, a subsidiary of JW Holdings, announced that it has developed a tablet formulation of Du...
Globally, the radiopharmaceutical medicine market is expected to reach USD 13.8 billion by 2024, according to a new repo...
A biologically-based alternative HIV treatment developed in Taiwan and manufactured in China has won approval from the U...
Singapore- Prometic Life Sciences Inc. announced that the U.S Food and Drug Administration (FDA) has granted a Rar...
Novo Nordisk, the world’s largest diabetes drugmaker has presented the first successful data from a large final-st...
A WuXi AppTec group company, STA Pharmaceutical Co., the leading open-access capability and technology platform for smal...
Orphan diseases, once rare, are now affecting larger populations, with one in every 5000 people suffering from a rare ge...
China based biotechnology company NetVation DL Medicine has entered into a two-year research collaboration with Pfizer I...
Singapore - A recent study observed a connection between male-pattern baldness, when it occurs at a young age, and the s...
Computation-driven pharmaceutical technology company XtalPi Inc. has closed a Series B funding round of $15 million led ...
Taiwan-based biopharma company OBI Pharma announced that it has received the US FDA nod for an investigational new drug ...
Singapore - Forty Seven, a US based clinical-stage company focused on developing the next generation of transformational...
Singapore - The U.S. Food and Drug Administration expanded the approved use of Lynparza (olaparib tablets) to include th...
Telix Pharmaceuticals , an Australian biopharmaceutical company focused on the development of diagnostic and therapeutic...
A clinical –stage biopharmaceutical company BerGenBio ASA has announced that the first efficacy endpoint has been ...
Intec Pharma is a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordio...
The U.S. pharmaceutical company, Pfizer has announced that it is abandoning research to find new drugs aimed at treating...
According to new research published in the Brain Research Journal, a drug developed for type 2 diabetes could possibly b...
